Prevention and treatment of bone infection with CSA-90

骨感染是治疗的一大挑战，特别是在抗药性“超级细菌”崛起的情况下。我们已经获得了一种新的试剂，CSA-90，它具有抗微生物(抗生素)的双重特性，并有助于促进骨骼生长。该项目旨在扩大我们先前的研究，并测试CsA-90用于治疗慢性骨感染。我们还将考虑将这项技术应用于关节置换，这种药物可能对涂覆矫形植入物特别有用。

Bone infections are a major challenge to treat, especially with the rise of drug resistant “superbugs”. We have access to a new agent, CSA-90, that has dual properties of being anti-microbial (antibiotic) and helps encourage bone growth. This project aims to expand upon our prior research and test CSA-90 for the treatment of chronic bone infections. We will also look at applying this technology to joint replacements and this drug may be particularly useful for coating orthopaedic implants.